KPMG LLP's Healthcare & Life Sciences Institute is pleased to continue its webcast series focusing on compliance in the life sciences industry. This month’s webcast features a discussion on regulatory considerations related to specific patient support program offerings. These include copay assistance, product discounts and adherence guidance.
To mitigate risk and maintain compliance when offering these programs, companies need to understand the regulatory requirements, specifically the requirement that prohibits federal healthcare beneficiary participation.
Join us on Wednesday, April 20, from 2:00 p.m. to 3:00 p.m. ET and hear our panel explore current copay assistance issues.
Dana McFerran and Greg Wiefel from KPMG's Risk Consulting practice will be joined by Andrew Ruskin, partner, from the law firm of Morgan Lewis. Our panelists will present and participate in an interactive discussion on how companies can:
Navigate the enforcement environment;
Understand compliance changes related to copay assistance programs; and